Regenerative Medicine

Regen Med

1746-0751

1746-076X

Therapeutic Area

Biotechnology, Cytology/Cell Biology, Health Policy, Molecular Medicine, Pharmacology

Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Cell Biologists, Cytologists, Molecular Biologists

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization. Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community. Regenerative Medicine exclusively supports all avenues that lead to the replacement or regeneration of human cells, tissue or organs, to restore or establish normal function. The sector is complex, rapidly evolving and multidisciplinary in nature, however, Regenerative Medicine is highly dynamic and has always embraced the progress made by the field and moved accordingly to support the critical issues including: Bench-to-bedside translation, Tissue engineering and organ replacement, Regenerative pharmacology, Cell and gene therapy, Regenerative nanotechnology, Manufacturing and cost of goods, Regulatory and reimbursement, Ethical and legal perspectives, Business models and commercialization, Government policy. Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

No associations affiliated with this journal

Future Medicine Ltd.

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines